Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer
Authors
Keywords
-
Journal
OncoImmunology
Volume 7, Issue 2, Pages e1387347
Publisher
Informa UK Limited
Online
2017-10-13
DOI
10.1080/2162402x.2017.1387347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues
- (2016) Saeid Zanganeh et al. Nature Nanotechnology
- Pro-apoptotic properties of (1,3)(1,4)-β-d-glucan from Avena sativa on human melanoma HTB-140 cells in vitro
- (2015) Andrzej Parzonko et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Anticancer properties of low molecular weight oat beta-glucan – An in vitro study
- (2015) Anna Choromanska et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype
- (2015) Min Liu et al. JOURNAL OF IMMUNOLOGY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints
- (2015) M. E. Mikucki et al. Nature Communications
- Immunostimulatory properties and antitumor activities of glucans
- (2013) LUCA VANNUCCI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Effects of orally administered yeast-derived beta-glucans: A review
- (2013) Anne Berit C. Samuelsen et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent
- (2013) Nandita Bose et al. Frontiers in Immunology
- Effect of molecular size and modification pattern on the internalization of water soluble β-(1→3)-(1→4)-glucan by primary murine macrophages
- (2012) Mei Zhang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived -glucans
- (2011) C. Qi et al. BLOOD
- Targeting the Immunoregulator SRA/CD204 Potentiates Specific Dendritic Cell Vaccine-Induced T-cell Response and Antitumor Immunity
- (2011) H. Yi et al. CANCER RESEARCH
- Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
- (2011) Sergio A. Quezada et al. IMMUNOLOGICAL REVIEWS
- IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells
- (2011) Daniel T. Fisher et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation
- (2009) H. Yi et al. BLOOD
- Combined yeast-derived β-glucan with anti-tumor monoclonal antibody for cancer immunotherapy
- (2009) Jingjing Liu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The effects of β-glucan on human immune and cancer cells
- (2009) Godfrey Chan et al. Journal of Hematology & Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search